1-2 POST-DOC/SENIOR RESEARCHER POSITIONS IN AUTOIMMUNITY GENOMICS AND SINGLE CELL TRANSCRIPTOMICS4.1.2017
Dr. Päivi Saavalainen’s research group at Research Programs Unit at Meilahti campus is seeking for 1-2 post-docs or senior researchers in immunogenetics, genomics and transcriptomics of human gastrointestinal inflammations, with a special focus on single cell RNAseq methodologies. The main research targets and hypotheses include clonality and phenotypes of gluten specific T and B cells in celiac disease, as well as drug response biomarkers in inflammatory bowel disease (IBD) patients on biological therapies. Extensive patient cohorts with existing exome/regulome/transcriptome NGS data are available or to be collected from both diseases. An ideal candidate holds a PhD degree in the fields of genetics, biochemistry, cell biology, molecular biology, bioinformatics or medicine. The candidate would be preferably skilled in and motivated on both wet lab work as well as analysis and interpretation of Illumina/Nanopore NGS data, but applications from pure bioinformaticians will be considered as well. Strong track record in genomics or transcriptomics fields, bioinformatics skills or background in immunological or microbiome studies will be highly appreciated. Successful candidate will also participate partly in the development of our local single cell RNAseq core facility (Drop-seq microfluidics), and in the management of new patient cohort collections.
The candidate is expected to be self-motivated and highly responsible with excellent scientific, troubleshooting, supervisory, communication and organization skills, as well as fluent in both spoken and written English. The salary will be based on education and experience according to the University salary system.
Application (in English) should include a 1 page cover letter with motivation, CV, list of publications, and contact information of at least two referees, as a single pdf-file sent to firstname.lastname@example.org by 15th Jan 2017 at latest. The position is initially for one year with a possibility for an extension. For further information please visit our website at http://research.med.helsinki.fi/immuno/saavalainen or contact Dr. Saavalainen (email@example.com , 050-4487487).